recombinant human Hyaluronidase(Shanghai Bao Pharma)

人玻璃酸酶(上海宝济药业)

Report date: 2026/04/03 17:40:50

Base Information

Drug Namerecombinant human Hyaluronidase(Shanghai Bao Pharma)
Drug Alias Name重组人透明质酸酶注射用人玻璃酸酶Hylenex recombinantVitrase
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionHyaluronic acid modulators
TargetsHyaluronic acid
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMainland China
Original Approved Date2026/03/31
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A